Considering the negative predictive value of LM in NSCLC from both the online database and real-world cohort, we conducted a meta-analysis to compare the different treatment outcomes of anti-PD-1/PD-L1 based therapies in NSCLC with versus without LM. Here, CD274 is linked to non-small cell lung carcinoma.